Insider Trades84 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Sell | ALNY | Melissa Mclaughlin | Chief Human Resources Officer | 3,910 | $325.92 | $35.7B | -46.03% | +0.39% | $1.3M | -2.36% | 10b5-1 | Trim |
| Mar 4, 2026 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 1,291 | $323.54 | $35.7B | -46.03% | +0.39% | $417.7K | -0.50% | 10b5-1 | Trim |
| Mar 4, 2026 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 2,309 | $323.08 | $35.7B | -46.03% | +0.39% | $746.0K | -0.81% | — | Trim |
| Mar 4, 2026 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 2,468 | $323.08 | $35.7B | -46.03% | +0.39% | $797.4K | -0.49% | — | Trim |
| Mar 4, 2026 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 2,933 | $323.08 | $35.7B | -46.03% | +0.39% | $947.6K | -0.38% | — | Trim |
| Mar 4, 2026 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 4,713 | $323.53 | $35.7B | -46.03% | +0.39% | $1.5M | -1.80% | 10b5-1 | Trim |
| Mar 2, 2026 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,598 | $327.65 | $35.7B | -46.03% | +0.39% | $523.6K | -0.42% | — | Trim |
| Mar 2, 2026 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 2,206 | $327.65 | $35.7B | -46.03% | +0.39% | $722.8K | -0.33% | — | Trim |
| Mar 2, 2026 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 3,250 | $323.62 | $35.7B | -46.03% | +0.39% | $1.1M | -0.95% | 10b5-1 | Trim |
| Mar 2, 2026 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 3,492 | $323.63 | $35.7B | -46.03% | +0.39% | $1.1M | -0.95% | 10b5-1 | Trim |
| Mar 2, 2026 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 6,799 | $327.65 | $35.7B | -46.03% | +0.39% | $2.2M | -0.59% | — | Trim |
| Feb 27, 2026 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 4,627 | $331.34 | $35.7B | -46.03% | +0.39% | $1.5M | -3.75% | 10b5-1 | Trim |
| Feb 13, 2026 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,959 | $310.08 | $35.7B | -46.03% | +0.39% | $607.4K | -5.81% | — | Trim |
| Feb 13, 2026 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 2,242 | $310.08 | $35.7B | -46.03% | +0.39% | $695.2K | -3.61% | — | Trim |
| Feb 13, 2026 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 2,242 | $310.08 | $35.7B | -46.03% | +0.39% | $695.2K | -8.28% | — | Trim |
| Feb 13, 2026 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 4,000 | $321.24 | $35.7B | -46.03% | +0.39% | $1.3M | -8.24% | 10b5-1 | Trim |
| Feb 13, 2026 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 6,958 | $310.08 | $35.7B | -46.03% | +0.39% | $2.2M | -7.51% | — | Trim |
| Jan 12, 2026 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,510 | $362.87 | $35.7B | -46.03% | +0.39% | $547.9K | -0.24% | — | Trim |
| Jan 12, 2026 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 1,510 | $362.87 | $35.7B | -46.03% | +0.39% | $547.9K | -0.31% | — | Trim |
| Jan 12, 2026 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 2,780 | $362.87 | $35.7B | -46.03% | +0.39% | $1.0M | -0.23% | — | Trim |
| Jan 12, 2026 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 3,800 | $367.37 | $35.7B | -46.03% | +0.39% | $1.4M | -0.59% | 10b5-1 | Trim |
| Jan 12, 2026 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 9,577 | $362.86 | $35.7B | -46.03% | +0.39% | $3.5M | -0.55% | — | Trim |
| Nov 26, 2025 | Buy | ALNY | Yvonne Greenstreet | Chief Executive Officer | 5,818 | $171.66 | $35.7B | -46.03% | +0.39% | $998.7K | +0.97% | — | Trim |
| Nov 17, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 20,289 | $318.21 | $35.7B | -46.03% | +0.39% | $6.5M | -1.34% | 10b5-1 | Trim |
| Nov 12, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 51,300 | $284.96 | $35.7B | -46.03% | +0.39% | $14.6M | +0.00% | 10b5-1 | Trim |
| Oct 2, 2025 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,405 | $452.05 | $35.7B | -46.03% | +0.39% | $635.1K | -0.42% | — | Trim |
| Oct 2, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 2,441 | $452.05 | $35.7B | -46.03% | +0.39% | $1.1M | -0.77% | — | Trim |
| Oct 2, 2025 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 3,821 | $452.05 | $35.7B | -46.03% | +0.39% | $1.7M | -0.57% | — | Trim |
| Oct 2, 2025 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 5,959 | $451.76 | $35.7B | -46.03% | +0.39% | $2.7M | -1.47% | 10b5-1 | Trim |
| Oct 2, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 8,924 | $452.05 | $35.7B | -46.03% | +0.39% | $4.0M | -1.06% | — | Trim |
| Aug 29, 2025 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 3,474 | $448.37 | $35.7B | -46.03% | +0.39% | $1.6M | -2.08% | 10b5-1 | Trim |
| Aug 18, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 1,396 | $453.27 | $35.7B | -46.03% | +0.39% | $632.8K | -0.74% | — | Trim |
| Aug 18, 2025 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,396 | $453.27 | $35.7B | -46.03% | +0.39% | $632.8K | -0.57% | — | Trim |
| Aug 18, 2025 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 2,274 | $453.27 | $35.7B | -46.03% | +0.39% | $1.0M | -0.55% | — | Trim |
| Aug 18, 2025 | Sell | ALNY | Pushkal Garg | EVP Chief R&D | 2,851 | $455.89 | $35.7B | -46.03% | +0.39% | $1.3M | -0.93% | 10b5-1 | Trim |
| Aug 18, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 6,979 | $453.27 | $35.7B | -46.03% | +0.39% | $3.2M | -1.43% | — | Trim |
| May 30, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 101,874 | $211.78 | $35.7B | -46.03% | +0.39% | $21.6M | +0.00% | 10b5-1 | Trim |
| May 16, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 8,376 | $285.31 | $35.7B | -46.03% | +0.39% | $2.4M | -14.61% | — | Trim |
| May 2, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 41,311 | $259.39 | $35.7B | -46.03% | +0.39% | $10.7M | -41.88% | — | Trim |
| Mar 21, 2025 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 15,211 | $203.46 | $35.7B | -46.03% | +0.39% | $3.1M | -6.14% | 10b5-1 | Trim |
| Mar 3, 2025 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 471 | $243.78 | $35.7B | -46.03% | +0.39% | $114.8K | -0.27% | — | Trim |
| Mar 3, 2025 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 1,264 | $243.78 | $35.7B | -46.03% | +0.39% | $308.1K | -0.36% | — | Trim |
| Mar 3, 2025 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 2,557 | $242.92 | $35.7B | -46.03% | +0.39% | $621.2K | -0.69% | 10b5-1 | Trim |
| Mar 3, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 2,755 | $242.94 | $35.7B | -46.03% | +0.39% | $669.3K | -1.26% | 10b5-1 | Trim |
| Mar 3, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 3,877 | $243.79 | $35.7B | -46.03% | +0.39% | $945.2K | -0.53% | — | Trim |
| Feb 28, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 496 | $241.69 | $35.7B | -46.03% | +0.39% | $119.9K | -0.49% | — | Trim |
| Feb 28, 2025 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 513 | $241.68 | $35.7B | -46.03% | +0.39% | $124.0K | -0.43% | — | Trim |
| Feb 28, 2025 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 796 | $241.70 | $35.7B | -46.03% | +0.39% | $192.4K | -0.29% | — | Trim |
| Feb 28, 2025 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 935 | $241.69 | $35.7B | -46.03% | +0.39% | $226.0K | -0.85% | — | Trim |
| Feb 28, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 2,900 | $241.69 | $35.7B | -46.03% | +0.39% | $700.9K | -0.42% | — | Trim |
| Feb 14, 2025 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 967 | $255.17 | $35.7B | -46.03% | +0.39% | $246.7K | -0.24% | — | Trim |
| Feb 14, 2025 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 1,213 | $255.17 | $35.7B | -46.03% | +0.39% | $309.5K | -0.12% | — | Trim |
| Feb 14, 2025 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 2,103 | $252.71 | $35.7B | -46.03% | +0.39% | $531.4K | -0.87% | 10b5-1 | Trim |
| Feb 14, 2025 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 3,109 | $253.43 | $35.7B | -46.03% | +0.39% | $787.9K | -1.28% | 10b5-1 | Trim |
| Jan 27, 2025 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 101,468 | $190.56 | $35.7B | -46.03% | +0.39% | $19.3M | -3.10% | 10b5-1 | Trim |
| Dec 12, 2024 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 1,752 | $251.00 | $35.7B | -46.03% | +0.39% | $439.8K | -1.51% | 10b5-1 | Trim |
| Nov 26, 2024 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,469 | $250.98 | $35.7B | -46.03% | +0.39% | $368.7K | -2.07% | — | Trim |
| Nov 26, 2024 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 1,682 | $250.98 | $35.7B | -46.03% | +0.39% | $422.1K | -1.06% | — | Trim |
| Nov 26, 2024 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 1,682 | $250.98 | $35.7B | -46.03% | +0.39% | $422.1K | -1.81% | — | Trim |
| Nov 26, 2024 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 3,000 | $251.65 | $35.7B | -46.03% | +0.39% | $754.9K | -2.27% | 10b5-1 | Trim |
| Nov 26, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 5,219 | $250.98 | $35.7B | -46.03% | +0.39% | $1.3M | -1.26% | — | Trim |
| Aug 20, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 30,000 | $182.50 | $35.7B | -46.03% | +0.39% | $5.5M | +0.00% | 10b5-1 | Trim |
| Aug 12, 2024 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 42,750 | $182.81 | $35.7B | -46.03% | +0.39% | $7.8M | -0.74% | 10b5-1 | Trim |
| Aug 1, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 30,296 | $177.50 | $35.7B | -46.03% | +0.39% | $5.4M | +0.00% | 10b5-1 | Trim |
| Jul 11, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 7,093 | $261.00 | $35.7B | -46.03% | +0.39% | $1.9M | -8.81% | 10b5-1 | Trim |
| Jun 25, 2024 | Sell | ALNY | Kevin Joseph Fitzgerald | CSO & EVP, Head of Research | 1,198 | $230.99 | $35.7B | -46.03% | +0.39% | $276.7K | -0.67% | — | Trim |
| Jun 25, 2024 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,605 | $231.00 | $35.7B | -46.03% | +0.39% | $370.7K | -1.05% | — | Trim |
| Jun 25, 2024 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 1,605 | $231.00 | $35.7B | -46.03% | +0.39% | $370.7K | -0.45% | — | Trim |
| Jun 25, 2024 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 2,103 | $230.99 | $35.7B | -46.03% | +0.39% | $485.8K | -1.03% | — | Trim |
| Jun 25, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 8,301 | $230.99 | $35.7B | -46.03% | +0.39% | $1.9M | -0.80% | — | Trim |
| Feb 28, 2024 | Sell | ALNY | Indrani Lall Franchini | EVP, CLO & Secretary | 329 | $155.30 | $35.7B | -46.03% | +0.39% | $51.1K | -1.43% | — | Trim |
| Feb 28, 2024 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 501 | $155.30 | $35.7B | -46.03% | +0.39% | $77.8K | -1.65% | — | Trim |
| Feb 28, 2024 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 574 | $155.30 | $35.7B | -46.03% | +0.39% | $89.1K | -1.19% | — | Trim |
| Feb 28, 2024 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 574 | $155.30 | $35.7B | -46.03% | +0.39% | $89.1K | -0.56% | — | Trim |
| Feb 28, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 2,932 | $155.31 | $35.7B | -46.03% | +0.39% | $455.4K | -1.14% | — | Trim |
| Feb 16, 2024 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 1,007 | $148.06 | $35.7B | -46.03% | +0.39% | $149.1K | -1.79% | — | Trim |
| Feb 16, 2024 | Sell | ALNY | Tolga Tanguler | EVP, Chief Commercial Officer | 1,009 | $148.06 | $35.7B | -46.03% | +0.39% | $149.4K | -7.22% | — | Trim |
| Feb 16, 2024 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 1,308 | $148.06 | $35.7B | -46.03% | +0.39% | $193.7K | -5.39% | — | Trim |
| Feb 16, 2024 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 7,030 | $148.06 | $35.7B | -46.03% | +0.39% | $1.0M | -4.76% | — | Trim |
| Feb 2, 2024 | Sell | ALNY | Indrani Lall Franchini | EVP, CLO & Secretary | 1,591 | $170.99 | $35.7B | -46.03% | +0.39% | $272.1K | -8.43% | — | Trim |
| Aug 4, 2023 | Sell | ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | 3,460 | $185.85 | $35.7B | -46.03% | +0.39% | $643.0K | -3.35% | — | Trim |
| Aug 4, 2023 | Sell | ALNY | Akshay Vaishnaw | President | 4,057 | $185.85 | $35.7B | -46.03% | +0.39% | $754.0K | -2.78% | — | Trim |
| Aug 4, 2023 | Sell | ALNY | Yvonne Greenstreet | Chief Executive Officer | 4,057 | $185.85 | $35.7B | -46.03% | +0.39% | $754.0K | -1.84% | — | Trim |
| Aug 4, 2023 | Sell | ALNY | Pushkal Garg | CMO & EVP Dev & Med Affairs | 7,627 | $184.78 | $35.7B | -46.03% | +0.39% | $1.4M | -9.82% | 10b5-1 | Trim |